Excerpt to provide quick access to emerging pathogen-related recommendations from the ORTP Guidance. The full guidance should be utilized with these recommendations.
ORTP Guidance
Tables and guides that can be downloaded, completed with individual/facility information, saved to a desktop, and printed.
CDC
Organization for Safety, Asepsis and Prevention (OSAP)
Links to MERS resources:
WHO 2014
Guidance for acute respiratory infection, ranging from routine to the epidemic, with brief but specific and well-referenced section on environmental controls:
CDC
MedlinePlus, US National Library of Medicine
CDC
Reviews modes of influenza transmission, fundamental elements to prevent transmission, recommendations:
OSHA
Specific to pandemic influenza. Addresses transportation to the hospital and the diagnostic and research laboratory setting. Table summarizes administrative and engineering controls, stratified by presence or absence of patient screening for a respiratory illness.
OSHA
Integrated into the OSHA guidance for environmental controls, includes:
WHO Europe
Checklist written for 2009 pandemic influenza. Resource for outbreak preparedness, mostly related to administrative controls
CDC
External links to:
CDC 2012
Offers 2 elements not found in the 2015 update:
AHRQ
UK.gov
CDC
Toolkit for patient notification of unsafe injection practices and other infection control lapses that may have exposed patients to microorganisms. Principles and tools applicable to any situation where patient notification is necessary. Includes patient notification and communication resources (Sections 1, 3, 4).
CDC
HHS
Flow chart for when health information should be disclosed for public health emergency preparedness
CDC Division of Vector Borne Diseases
Current outbreak information, background, guidance on vector-borne diseases
CDC
Guidance for:
CDC
Situational updates on current outbreaks and recalls in the US and worldwide
CDC
CDC GovDelivery
CDC
CDC
| CDC and the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) |
Joint communication and data collection network organized by the International Society of Travel Medicine and CDC. Reports and data available, and an extensive bibliography with references on global health infectious disease surveillance and emerging infectious diseases.
FDA
FDA
WHO International
WHO
WHO
Organized by WHO Disease Outbreak News (DON) to provide:
HHS.gov
Commissioned by Public Health England to give up-to-date information on global outbreak surveillance. Can be searched by country or disease and provides links to external governmental websites. Information is gathered by different sources including government reports, international organizations, and media reports, and each is accompanied with a verification status.
Updated information on emerging infectious diseases of global importance. Map with highlighted areas with suspected outbreak activity. Users can select links to obtain more information and reports from government and public health agencies.
Interventions and strategies needed to prevent situation in one’s facility
Descriptive study of the healthcare facility transmission of MERS-CoV to a number of patients. Highlights how overcrowding in emergency departments and failing to identify and isolate infected patients contributed to the outbreak.
Cho SY, Jang J-M, Ha YE, et al. MERS-CoV outbreak following single patient exposure in an emergency room in South Korea: an epidemiological outbreak study. Lancet 2016; 388:994-1001.
Practical advice for implementing prevention and control measures for EVD and other hemorrhagic virus infections
How a community hospital implemented administrative, engineering, and personal protective equipment controls in order to safely and effectively manage patients with EVD.
Cummings KJ, Choi MJ, Esswein EJ, et al. Addressing infection prevention and control in the first U.S. community hospital to care for patients with Ebola virus disease: context for national recommendations and future strategies. Ann Intern Med 2017; 165: 41-9.
MMWR
First description of C. auris cases in the United States. U.S. isolates are related to isolates from South America and South Asia. Evidence from U.S. case investigations suggests likely transmission of the organism occurred in healthcare settings. It is important that U.S. laboratories accurately identify C. auris and for healthcare facilities to implement recommended infection control practices to prevent the spread of C. auris. Local and state health departments and CDC should be notified of possible cases of C. auris and of isolates of C. haemulonii and Candida spp. that cannot be identified after routine testing.
Vallabhaneni S, Kallen A, Tsay S, et al. Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus — United States, May 2013–August 2016. MMWR Morb Mortal Wkly Rep 2016;65:1234–1237. DOI: http://dx.doi.org/10.15585/mmwr.mm6544e1
Review article on clinical features, natural history, case definition and predictive value, diagnosis, treatment, transmission of risk factors.
Vincent C.C. Cheng, Jasper F.W. Chan, Kelvin K.W. To, K.Y. Yuen, Clinical management and infection control of SARS: Lessons learned, Antiviral Research, Volume 100, Issue 2, 2013, Pages 407-419, ISSN 0166-3542, https://doi.org/10.1016/j.antiviral.2013.08.016.
May L. Case Study: The Toronto SARS II Experience. Chapter in Hunting and Gleason. Essential Case Studies in Public Health: Putting Public Health into Practice. Jones and Bartlett Publishers